Skip to main content

TianTi Biotherapeutics

Woburn, United States

TianTi Biotherapeutics is a biotechnology company that provides research and development of antibody drugs.

$15.6M raised
Dec 2021
Series A

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TianTi Biotherapeutics

How much funding has TianTi Biotherapeutics raised?
TianTi Biotherapeutics has raised $15.6M in total funding. The most recent round was Series A. The last funding was announced in December 2021.
Who are TianTi Biotherapeutics's investors?
TianTi Biotherapeutics's investors include Cathay Capital, Oriza Holdings, Guangzhou Yuexiu Industrial Investment Fund, Shanghai Biomedical Industrial Equity Investment Fund, Kaitai Capital.
Where is TianTi Biotherapeutics headquartered?
TianTi Biotherapeutics is headquartered in Woburn, United States.
What does TianTi Biotherapeutics do?
TianTi Biotherapeutics is a biotechnology company that provides research and development of antibody drugs.
What stage is TianTi Biotherapeutics at?
TianTi Biotherapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"TianTi Biotherapeutics — Funding & Investors." VCBacked, December 20, 2021, https://www.vcbacked.co/company/tianti-biotherapeutics. Accessed July 3, 2026.
APA
VCBacked. (2021). TianTi Biotherapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/tianti-biotherapeutics
Wikipedia (cite web)
{{cite web |title=TianTi Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tianti-biotherapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .